The Emerging Parkinson's Disease Oxylipin-Ome. Research Advanced science (Weinheim, Baden-Wurttemberg, Germany) April 22, 2026
Safety Evaluation of Intravenous Talineuren (TLN) in Parkinson's Disease-affected Patients Trial Phase 1 Terminated April 21, 2026
Amyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD Pathology Trial N/A Not yet recruiting April 21, 2026
Predictive Factors and Subthalamic Stimulation in Parkinson's Disease Trial N/A Completed April 21, 2026
Rethinking our strategies to develop disease-modifying therapies for Parkinson's: Time for combination therapies? News SAGE Publications: Journal of Parkinson’s Disease: Table of Contents April 21, 2026
C3 and C5 complement cascade activation in brain injury and disease: Molecular mechanisms, pathological roles, and therapeutic implications. Research Neurochemistry international April 21, 2026
Correction: AI-Enabled Wearables for Motor Function Assessment and Rehabilitation in Parkinson Disease: Scoping Review. Research Journal of medical Internet research April 21, 2026
Deep brain stimulation in VPS13C-associated Parkinson's disease: a longitudinal case study. Research Clinical parkinsonism & related disorders April 21, 2026
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease Trial N/A Completed April 20, 2026
A System to Help With Freezing of Gait in Parkinson's Patients Trial N/A Not yet recruiting April 20, 2026
Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients Trial Phase 1 Recruiting April 20, 2026
Alzheimer neuropathological change, α-synuclein and transactive response DNA-binding protein of 43 kDa expression in children and young adult brains from forensic autopsies: Value for early measurement of abnormal protein expression prevalence in neurodegenerative diseases. Research Journal of neuropathology and experimental neurology April 20, 2026
Novel insight into PINK1/parkin-associated autophagy implicated in Parkinson disease. Research Translational neuroscience April 20, 2026
rTMS Over the Dorsolateral Prefrontal Cortex for the Treatment of Impulse Control Disorders in Parkinson's Disease Trial N/A Recruiting April 19, 2026
Effects of Cognitive Dual-Task on Gait in Parkinson's Disease Trial N/A Not yet recruiting April 19, 2026
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease Trial Phase 1 Recruiting April 19, 2026